Remove 2023 Remove Biotechnology Remove Strategic partnership
article thumbnail

LabVantage Solutions Applauded by Frost & Sullivan for Its Industry-leading Flexible, Scalable, and Cost-effective LIMS Solutions

Frost & Sullivan

It has established itself as a leading LIMS provider globally and was recognized as the highest-ranking LIMS vendor in growth and innovation in Frost & Sullivan’s first Frost Radar™ report for LIMS in 2023 and 2024. LabVantage LIMS is an enterprise platform serving the full product life cycle.

article thumbnail

Avance Clinical Earns Frost & Sullivan’s 2023 Best Practices Customer Value Leadership Award for Delivering High-quality Clinical Trials Based on Globally Accepted Data

Frost & Sullivan

San Antonio, TX — 7 th Aug, 2023 — Frost & Sullivan recently researched the Asia-Pacific biotechnology contract research organization industry and, based on its findings, recognizes Avance Clinical with the 2023 Customer Value Leadership Award.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Technology Convergence Driving the Development of Sustainable Crop Protection Solutions

Frost & Sullivan

17, 2023– The agricultural industry’s ongoing changes—rapid climate change and biodiversity loss—have created a lucrative growth opportunity for agrochemical technology developers. Form strategic partnerships for new product development. San Antonio – Jan.

article thumbnail

Pharma & Biotech in 2025: The Top 6 Growth Opportunities Shaping the Future

Frost & Sullivan

The pharmaceutical and biotechnology industries are at the cusp of a transformative era in 2025, driven by cutting-edge innovation, evolving regulations, and increasing market pressures. Between 2017 and 2023, the US RLT market saw over 550% growth in total venture capital deals. The market for RLT is set for exponential growth.

Biotech 52